CN Patent

CN115151544B — β-内酰胺酶抑制剂及其制备

Assigned to Ningxia Academy of Agriculture and Forestry Sciences · Expires 2024-08-16 · 2y expired

What this patent protects

本发明提供了新的β‑内酰胺酶抑制剂，其用于与β‑内酰胺类抗生素联合治疗细菌感染，包括由耐药性生物体和特别是多重耐药性生物体引起的感染。本发明包括根据式(I)的化合物或其可药用盐，其中M和R如本文中所定义。

USPTO Abstract

本发明提供了新的β‑内酰胺酶抑制剂，其用于与β‑内酰胺类抗生素联合治疗细菌感染，包括由耐药性生物体和特别是多重耐药性生物体引起的感染。本发明包括根据式(I)的化合物或其可药用盐，其中M和R如本文中所定义。

Drugs covered by this patent

Patent Metadata

Patent number: CN115151544B
Jurisdiction: CN
Classification: —
Expires: 2024-08-16
Drug substance claim: No
Drug product claim: No
Assignee: Ningxia Academy of Agriculture and Forestry Sciences
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.